DK0858341T3 - Kombinationsbehandling af fremskreden cancer omfattende temozolomid og cisplatin - Google Patents
Kombinationsbehandling af fremskreden cancer omfattende temozolomid og cisplatinInfo
- Publication number
- DK0858341T3 DK0858341T3 DK96930553T DK96930553T DK0858341T3 DK 0858341 T3 DK0858341 T3 DK 0858341T3 DK 96930553 T DK96930553 T DK 96930553T DK 96930553 T DK96930553 T DK 96930553T DK 0858341 T3 DK0858341 T3 DK 0858341T3
- Authority
- DK
- Denmark
- Prior art keywords
- cisplatin
- advanced cancer
- combination therapy
- cancer including
- including temozolomide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US287795P | 1995-08-28 | 1995-08-28 | |
US62479596A | 1996-03-27 | 1996-03-27 | |
PCT/US1996/013479 WO1997007804A1 (en) | 1995-08-28 | 1996-08-26 | Combination therapy for advanced cancer comprising temozolomide and cisplatin |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0858341T3 true DK0858341T3 (da) | 2001-11-19 |
Family
ID=26670993
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK96930553T DK0858341T3 (da) | 1995-08-28 | 1996-08-26 | Kombinationsbehandling af fremskreden cancer omfattende temozolomid og cisplatin |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0858341B1 (es) |
JP (1) | JPH10511108A (es) |
AT (1) | ATE207359T1 (es) |
AU (1) | AU6955396A (es) |
CA (1) | CA2229141A1 (es) |
DE (1) | DE69616367T2 (es) |
DK (1) | DK0858341T3 (es) |
ES (1) | ES2162092T3 (es) |
GR (1) | GR3037047T3 (es) |
PT (1) | PT858341E (es) |
WO (1) | WO1997007804A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE330600T1 (de) * | 2000-01-26 | 2006-07-15 | Schering Corp | Kombinationspräparat zur krebstherapie |
CN101370497B (zh) * | 2006-01-17 | 2010-11-17 | 雅培制药有限公司 | 包含parp抑制剂和细胞毒性剂的联合产品及用途 |
SG10201500027TA (en) | 2006-04-05 | 2015-02-27 | Opko Health Inc | Hydrochloride salts of 8-[{1-(3,5-bis-(trifluoromethyl) phenyl) -ethoxy}-methyl] -8-phenyl-1,7-diaza-spiro[4.5] decan-2-one and preparation process therefor |
WO2007114921A2 (en) | 2006-04-05 | 2007-10-11 | Schering Corporation | Pharmaceutical formulations: salts of 8-[{1-(3,5-bis (trifluoromethy1)pheny1)-e thoxy}-methy1]-8-pheny1-1,7-diaza-spiro[4.5] decan-2-one and treatment methods using the same |
WO2010081823A1 (en) * | 2009-01-13 | 2010-07-22 | Proteosys Ag | Pirenzepine as otoprotective agent |
EP4090431A4 (en) * | 2020-01-13 | 2024-01-24 | Memorial Sloan Kettering Cancer Center | METHODS AND COMPOSITIONS FOR CANCER IMMUNOTHERAPY |
-
1996
- 1996-08-26 EP EP96930553A patent/EP0858341B1/en not_active Expired - Lifetime
- 1996-08-26 JP JP9510392A patent/JPH10511108A/ja active Pending
- 1996-08-26 DE DE69616367T patent/DE69616367T2/de not_active Expired - Lifetime
- 1996-08-26 ES ES96930553T patent/ES2162092T3/es not_active Expired - Lifetime
- 1996-08-26 PT PT96930553T patent/PT858341E/pt unknown
- 1996-08-26 AU AU69553/96A patent/AU6955396A/en not_active Abandoned
- 1996-08-26 WO PCT/US1996/013479 patent/WO1997007804A1/en active IP Right Grant
- 1996-08-26 AT AT96930553T patent/ATE207359T1/de not_active IP Right Cessation
- 1996-08-26 CA CA002229141A patent/CA2229141A1/en not_active Abandoned
- 1996-08-26 DK DK96930553T patent/DK0858341T3/da active
-
2001
- 2001-10-30 GR GR20010401919T patent/GR3037047T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
GR3037047T3 (en) | 2002-01-31 |
EP0858341A1 (en) | 1998-08-19 |
CA2229141A1 (en) | 1997-03-06 |
ATE207359T1 (de) | 2001-11-15 |
AU6955396A (en) | 1997-03-19 |
JPH10511108A (ja) | 1998-10-27 |
PT858341E (pt) | 2002-03-28 |
ES2162092T3 (es) | 2001-12-16 |
WO1997007804A1 (en) | 1997-03-06 |
MX9801585A (es) | 1998-05-31 |
EP0858341B1 (en) | 2001-10-24 |
DE69616367D1 (de) | 2001-11-29 |
DE69616367T2 (de) | 2002-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69532961D1 (de) | Verwendung von porphyrine in der behandlung von multiple sklerose | |
FI971290A (fi) | Multippeliskleroosin (MS) ja muiden myeliinikadosta aiheutuvien sairauksien hoito | |
GEP20002146B (en) | Therapeutic Peptide Derivatives | |
KR950700749A (ko) | 2'-할로메틸리덴 유도체와 S-기 또는 M-기 특이성 항종양제를 사용하는 결합치료에 의한 암치료 방법(Method of treating cancer by conjunctive therapy with 2'-halomethylidene derivatives and a S-phase or M phase specific antineoplastic agent) | |
DE69617469D1 (de) | Behandlung von multipler sklerose | |
CY1108629T1 (el) | Συνδυασμος ετ 743 με 5 φθοριοουρακιλο προ-φαρμακα δια την θεραπευτικη αγωγη του καρκικου | |
DE69426334D1 (de) | Parenterales Busulfan zur Behandlung von malignen Krankheiten | |
DE69424777D1 (de) | 3,4-diarylchromane zur behandlung von dermatitis | |
CY1105564T1 (el) | Θεραπεια συνδυασμου για καρκινο | |
DK0837935T3 (da) | Den 3'-ikke-translaterede region af det humane prohibitin-gen | |
ATE327800T1 (de) | Behandlung von darm- oder blasenentzündungen | |
DK0858341T3 (da) | Kombinationsbehandling af fremskreden cancer omfattende temozolomid og cisplatin | |
DK0986393T3 (da) | Anvendelse af et nitroxid eller et prodrug heraf ved profylaktisk og terapeutisk behandling af cancer | |
IL121440A0 (en) | The use of 1,3,4,6-tetrahydroxy-helianthrone and its derivatives in photodynamic therapy and certain such novel derivatives | |
DK0859630T3 (da) | Kombination af termozolomid og alfa-IFN til behandling af fremskreden cancer | |
ATE149840T1 (de) | Behandlung von leberkrebs | |
NO984196L (no) | FremgangsmÕte for behandling av stoffmisbruk | |
NO984198L (no) | FremgangsmÕte for behandling av aggresjon | |
SU1823193A1 (ru) | Способ лечения рака гортани | |
MX9603833A (es) | Tratamiento mejorado del cancer con temozolomida. | |
UA10928C2 (uk) | Спосіб профілактики гіперхолестериhемії | |
WO2000033823A3 (en) | Methods of using temozolomide in the treatment of cancers | |
UA10221A (uk) | Спосіб лікування рецидивного бронхіту у дітей | |
UA28928A (uk) | Спосіб лікування гнійно-запальних захворювань м'яких тканин | |
RU97114158A (ru) | Способ лечения злокачественных опухолей |